Author:
Glurich Ingrid,Burmester James K.,Caldwell Michael D.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference52 articles.
1. Wysowski DK, Nourjah P, Swartz L (2007) Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med 167:1414–1419. doi: 10.1001/archinte.167.13.1414
2. Horton JD, Bushwick BM (1999) Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician 59:635–646
3. Centers for Disease Control, and Prevention (CDC) (2007) Prevalence of stroke–United States, 2005. MMWR Morb Mortal Wkly Rep 56:469–474
4. Evans A, Davis S, Kilpatrick C, Gerraty R, Campbell D, Greenberg P (2002) The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable. J Clin Neurosci 9:268–272. doi: 10.1054/jocn.2001.1018
5. Garrett AD (2007) New oral anticoagulants under study. In: Pharmacy Times, May, p 49. http://www.pharmacytimes.com/issues/articles/2007-05_4655.asp . Accessed 13 May 2008
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献